Wednesday - April 24, 2024

Category Archives: Finance

Excia Asia, The Leading Name in Premium Industrial PPE, Announces Revolutionary Range of Industrial Coveralls and More

Elevating Safety, Comfort, and Efficiency Through Quality-driven Personal Protective Equipment (PPE) In today’s work ecosystem, the provision of top-tier Personal Protective Equipment (PPE) is not just a requirement but a moral obligation that represents an organization’s commitment to employee well-being … Continue reading →

Systemic Sclerosis Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Acceleron, Accuitis, AnaMar, arGentis, Bayer, BriaCell

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 50+ key pharma and biotech companies are working on 50+ pipeline drugs in the Systemic Sclerosis therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and … Continue reading →

Eosinophilic Esophagitis Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Allakos, Aqilion, Calypso, Ellodi, EsoCap, Serpin

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 18+ key pharma and biotech companies are working on 20+ pipeline drugs in the Eosinophilic Esophagitis therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and … Continue reading →

Limb-Girdle Muscular Dystrophy (LGMD) Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Asklepios, Myonexus, Sarepta, Atamyo

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 20+ key pharma and biotech companies are working on 25+ pipeline drugs in the Limb-Girdle Muscular Dystrophy therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), … Continue reading →

Cystic Fibrosis Market Gearing Up for Outstanding Expansion During the Forecast Period (2023-32) | Translate Bio, Novartis, Algi Pharma, Calithera, Santhera, Reveragen, Spli Sense, EmphyCorp, Abbvie

Delveinsight Business Research LLP The Cystic Fibrosis therapeutic market size in the 7MM was USD 7,134 million in 2021, which is expected to grow by 2032. As per DelveInsight, the Cystic Fibrosis Market is anticipated to evolve immensely in the … Continue reading →

Niemann-Pick Disease Type C (NPC) Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Mandos, Orphazyme, IntraBio, SOM Biotech

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 13+ key pharma and biotech companies are working on 13+ pipeline drugs in the Niemann-Pick Disease Type C therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action … Continue reading →